Literature DB >> 19347777

Volumetric MRI studies of the hippocampus in major depressive disorder: Meanings of inconsistency and directions for future research.

Cagdas Eker1, Ali Saffet Gonul.   

Abstract

There are numerous magnetic resonance imaging (MRI) studies investigating the hippocampal volumetric differences between depressed and healthy subjects. Although there are inconsistencies among study results, a smaller hippocampal volume in depressed patients is thought to be related to the pathophysiology of the disease. Many factors appear to affect hippocampal volumes in major depressive disorder patients. Among these factors, recurrency, severity and the individual patient are the most pronounced. Patient groups with a mean age older than 40 years, or samples consisting of patients who have had severe or multiple episodes are more likely to demonstrate smaller hippocampal volumes. The possible causes of this relationship are discussed to give new perspectives to future research.

Entities:  

Mesh:

Year:  2010        PMID: 19347777     DOI: 10.1080/15622970902737998

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  20 in total

1.  Volumetric brain differences in clinical depression in association with anxiety: a systematic review with meta-analysis.

Authors:  Daniela A Espinoza Oyarce; Marnie E Shaw; Khawlah Alateeq; Nicolas Cherbuin
Journal:  J Psychiatry Neurosci       Date:  2020-11-01       Impact factor: 6.186

2.  Development and evaluation of a multimodal marker of major depressive disorder.

Authors:  Jie Yang; Mengru Zhang; Hongshik Ahn; Qing Zhang; Tony B Jin; Ien Li; Matthew Nemesure; Nandita Joshi; Haoran Jiang; Jeffrey M Miller; Robert Todd Ogden; Eva Petkova; Matthew S Milak; Mary Elizabeth Sublette; Gregory M Sullivan; Madhukar H Trivedi; Myrna Weissman; Patrick J McGrath; Maurizio Fava; Benji T Kurian; Diego A Pizzagalli; Crystal M Cooper; Melvin McInnis; Maria A Oquendo; Joseph John Mann; Ramin V Parsey; Christine DeLorenzo
Journal:  Hum Brain Mapp       Date:  2018-08-16       Impact factor: 5.038

3.  Medial temporal lobe atrophy in Alzheimer's disease/mild cognitive impairment with depression.

Authors:  V Dhikav; M Sethi; K S Anand
Journal:  Br J Radiol       Date:  2014-07-25       Impact factor: 3.039

4.  Abnormal hippocampal activation in patients with extensive history of major depression: an fMRI study.

Authors:  Andrea M B Milne; Glenda M MacQueen; Geoffrey B C Hall
Journal:  J Psychiatry Neurosci       Date:  2012-01       Impact factor: 6.186

Review 5.  Shared neurobiological pathways between type 2 diabetes and depressive symptoms: a review of morphological and neurocognitive findings.

Authors:  Todd Doyle; Angelos Halaris; Murali Rao
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

Review 6.  Brain structure alterations in depression: Psychoradiological evidence.

Authors:  Fei-Fei Zhang; Wei Peng; John A Sweeney; Zhi-Yun Jia; Qi-Yong Gong
Journal:  CNS Neurosci Ther       Date:  2018-03-05       Impact factor: 5.243

Review 7.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

8.  Changes of grey matter volume in first-episode drug-naive adult major depressive disorder patients with different age-onset.

Authors:  Zonglin Shen; Yuqi Cheng; Shuran Yang; Nan Dai; Jing Ye; Xiaoyan Liu; Jin Lu; Na Li; Fang Liu; Yi Lu; Xuejin Sun; Xiufeng Xu
Journal:  Neuroimage Clin       Date:  2016-08-24       Impact factor: 4.881

Review 9.  Analysis of morphological changes as a key method in studying psychiatric animal models.

Authors:  Oliver von Bohlen und Halbach
Journal:  Cell Tissue Res       Date:  2013-01-20       Impact factor: 5.249

Review 10.  Effects of diabetes on hippocampal neurogenesis: links to cognition and depression.

Authors:  Nancy Ho; Marilyn S Sommers; Irwin Lucki
Journal:  Neurosci Biobehav Rev       Date:  2013-05-13       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.